 | • レポートコード：MRC2012A4097 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、胃がん治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。胃がん治療薬の種類別市場規模（ドキソルビシン塩酸塩、スニチニブ、ドセタキセル、ミトマイシン、フルオロウラシル、イマチニブ、トラスツズマブ）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、AstraZeneca、Otsuka Pharmaceutical、Eli Lilly、Merck、F. Hoffmann-La Roche、Daiichi-Sankyo、Amgen、Novartis、Boehringer Ingelheim、Bayer HealthCare、 ・地域別グローバル市場分析 2015年-2020年 ・胃がん治療薬の北米市場（アメリカ、カナダ、メキシコ） ・胃がん治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・胃がん治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・胃がん治療薬の南米市場（ブラジル、アルゼンチン） ・胃がん治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ドキソルビシン塩酸塩、スニチニブ、ドセタキセル、ミトマイシン、フルオロウラシル、イマチニブ、トラスツズマブ ・用途別分析：病院、診療所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Gastric Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1597 million by 2025, from USD 1152.4 million in 2019.
The Gastric Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Gastric Cancer Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gastric Cancer Drugs market has been segmented into
Doxorubicin Hydrochloride
Sunitinib
Docetaxel
Mitomycin
Fluorouracil
Imatinib
Trastuzumab
By Application, Gastric Cancer Drugs has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gastric Cancer Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Gastric Cancer Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gastric Cancer Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Gastric Cancer Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Gastric Cancer Drugs Market Share Analysis
Gastric Cancer Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gastric Cancer Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gastric Cancer Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Gastric Cancer Drugs are:
Sanofi
AstraZeneca
Otsuka Pharmaceutical
Eli Lilly
Merck
F. Hoffmann-La Roche
Daiichi-Sankyo
Amgen
Novartis
Boehringer Ingelheim
Bayer HealthCare
Among other players domestic and global, Gastric Cancer Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastric Cancer Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastric Cancer Drugs, with price, sales, revenue and global market share of Gastric Cancer Drugs in 2018 and 2019.
Chapter 3, the Gastric Cancer Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastric Cancer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gastric Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gastric Cancer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Gastric Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastric Cancer Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Doxorubicin Hydrochloride
1.2.3 Sunitinib
1.2.4 Docetaxel
1.2.5 Mitomycin
1.2.6 Fluorouracil
1.2.7 Imatinib
1.2.8 Trastuzumab
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastric Cancer Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Overview of Global Gastric Cancer Drugs Market
1.4.1 Global Gastric Cancer Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AstraZeneca SWOT Analysis
2.2.4 AstraZeneca Product and Services
2.2.5 AstraZeneca Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Otsuka Pharmaceutical
2.3.1 Otsuka Pharmaceutical Details
2.3.2 Otsuka Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Otsuka Pharmaceutical SWOT Analysis
2.3.4 Otsuka Pharmaceutical Product and Services
2.3.5 Otsuka Pharmaceutical Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eli Lilly SWOT Analysis
2.4.4 Eli Lilly Product and Services
2.4.5 Eli Lilly Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 F. Hoffmann-La Roche
2.6.1 F. Hoffmann-La Roche Details
2.6.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 F. Hoffmann-La Roche SWOT Analysis
2.6.4 F. Hoffmann-La Roche Product and Services
2.6.5 F. Hoffmann-La Roche Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Daiichi-Sankyo
2.7.1 Daiichi-Sankyo Details
2.7.2 Daiichi-Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Daiichi-Sankyo SWOT Analysis
2.7.4 Daiichi-Sankyo Product and Services
2.7.5 Daiichi-Sankyo Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Amgen SWOT Analysis
2.8.4 Amgen Product and Services
2.8.5 Amgen Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis SWOT Analysis
2.9.4 Novartis Product and Services
2.9.5 Novartis Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Boehringer Ingelheim
2.10.1 Boehringer Ingelheim Details
2.10.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Boehringer Ingelheim SWOT Analysis
2.10.4 Boehringer Ingelheim Product and Services
2.10.5 Boehringer Ingelheim Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bayer HealthCare
2.11.1 Bayer HealthCare Details
2.11.2 Bayer HealthCare Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bayer HealthCare SWOT Analysis
2.11.4 Bayer HealthCare Product and Services
2.11.5 Bayer HealthCare Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gastric Cancer Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gastric Cancer Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gastric Cancer Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Gastric Cancer Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gastric Cancer Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Gastric Cancer Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gastric Cancer Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
4.5 South America Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gastric Cancer Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Gastric Cancer Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Gastric Cancer Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gastric Cancer Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Gastric Cancer Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gastric Cancer Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
6.3 UK Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
6.4 France Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gastric Cancer Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gastric Cancer Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gastric Cancer Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
7.5 India Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gastric Cancer Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Gastric Cancer Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Gastric Cancer Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gastric Cancer Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gastric Cancer Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gastric Cancer Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gastric Cancer Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Gastric Cancer Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Gastric Cancer Drugs Price by Type (2015-2020)
11 Global Gastric Cancer Drugs Market Segment by Application
11.1 Global Gastric Cancer Drugs Sales Market Share by Application (2015-2020)
11.2 Global Gastric Cancer Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Gastric Cancer Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gastric Cancer Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Gastric Cancer Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Gastric Cancer Drugs Market Forecast (2021-2025)
12.2.2 Europe Gastric Cancer Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gastric Cancer Drugs Market Forecast (2021-2025)
12.2.4 South America Gastric Cancer Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gastric Cancer Drugs Market Forecast (2021-2025)
12.3 Gastric Cancer Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Gastric Cancer Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Gastric Cancer Drugs Market Share Forecast by Type (2021-2025)
12.4 Gastric Cancer Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Gastric Cancer Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Gastric Cancer Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Gastric Cancer Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gastric Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gastric Cancer Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Gastric Cancer Drugs Major Business
Table 9. Sanofi Gastric Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Sanofi SWOT Analysis
Table 11. Sanofi Gastric Cancer Drugs Product and Services
Table 12. Sanofi Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Gastric Cancer Drugs Major Business
Table 15. AstraZeneca Gastric Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 16. AstraZeneca SWOT Analysis
Table 17. AstraZeneca Gastric Cancer Drugs Product and Services
Table 18. AstraZeneca Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Otsuka Pharmaceutical Gastric Cancer Drugs Major Business
Table 21. Otsuka Pharmaceutical Gastric Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Otsuka Pharmaceutical SWOT Analysis
Table 23. Otsuka Pharmaceutical Gastric Cancer Drugs Product and Services
Table 24. Otsuka Pharmaceutical Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 26. Eli Lilly Gastric Cancer Drugs Major Business
Table 27. Eli Lilly Gastric Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Eli Lilly SWOT Analysis
Table 29. Eli Lilly Gastric Cancer Drugs Product and Services
Table 30. Eli Lilly Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Merck Basic Information, Manufacturing Base and Competitors
Table 32. Merck Gastric Cancer Drugs Major Business
Table 33. Merck Gastric Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Merck SWOT Analysis
Table 35. Merck Gastric Cancer Drugs Product and Services
Table 36. Merck Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 38. F. Hoffmann-La Roche Gastric Cancer Drugs Major Business
Table 39. F. Hoffmann-La Roche Gastric Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 40. F. Hoffmann-La Roche SWOT Analysis
Table 41. F. Hoffmann-La Roche Gastric Cancer Drugs Product and Services
Table 42. F. Hoffmann-La Roche Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Daiichi-Sankyo Basic Information, Manufacturing Base and Competitors
Table 44. Daiichi-Sankyo Gastric Cancer Drugs Major Business
Table 45. Daiichi-Sankyo Gastric Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Daiichi-Sankyo SWOT Analysis
Table 47. Daiichi-Sankyo Gastric Cancer Drugs Product and Services
Table 48. Daiichi-Sankyo Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Amgen Basic Information, Manufacturing Base and Competitors
Table 50. Amgen Gastric Cancer Drugs Major Business
Table 51. Amgen Gastric Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Amgen SWOT Analysis
Table 53. Amgen Gastric Cancer Drugs Product and Services
Table 54. Amgen Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Novartis Basic Information, Manufacturing Base and Competitors
Table 56. Novartis Gastric Cancer Drugs Major Business
Table 57. Novartis Gastric Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Novartis SWOT Analysis
Table 59. Novartis Gastric Cancer Drugs Product and Services
Table 60. Novartis Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 62. Boehringer Ingelheim Gastric Cancer Drugs Major Business
Table 63. Boehringer Ingelheim Gastric Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Boehringer Ingelheim SWOT Analysis
Table 65. Boehringer Ingelheim Gastric Cancer Drugs Product and Services
Table 66. Boehringer Ingelheim Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table 68. Bayer HealthCare Gastric Cancer Drugs Major Business
Table 69. Bayer HealthCare Gastric Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Bayer HealthCare SWOT Analysis
Table 71. Bayer HealthCare Gastric Cancer Drugs Product and Services
Table 72. Bayer HealthCare Gastric Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Gastric Cancer Drugs Sales by Manufacturer (2018-2019) (K Pcs)
Table 74. Global Gastric Cancer Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Gastric Cancer Drugs Sales by Regions (2015-2020) (K Pcs)
Table 76. Global Gastric Cancer Drugs Sales Market Share by Regions (2015-2020)
Table 77. Global Gastric Cancer Drugs Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Gastric Cancer Drugs Sales by Countries (2015-2020) (K Pcs)
Table 79. North America Gastric Cancer Drugs Sales Market Share by Countries (2015-2020)
Table 80. North America Gastric Cancer Drugs Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Gastric Cancer Drugs Revenue Market Share by Countries (2015-2020)
Table 82. Europe Gastric Cancer Drugs Sales by Countries (2015-2020) (K Pcs)
Table 83. Europe Gastric Cancer Drugs Sales Market Share by Countries (2015-2020)
Table 84. Europe Gastric Cancer Drugs Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Gastric Cancer Drugs Sales by Regions (2015-2020) (K Pcs)
Table 86. Asia-Pacific Gastric Cancer Drugs Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Gastric Cancer Drugs Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Gastric Cancer Drugs Sales by Countries (2015-2020) (K Pcs)
Table 89. South America Gastric Cancer Drugs Sales Market Share by Countries (2015-2020)
Table 90. South America Gastric Cancer Drugs Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Gastric Cancer Drugs Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Gastric Cancer Drugs Sales by Countries (2015-2020) (K Pcs)
Table 93. Middle East & Africa Gastric Cancer Drugs Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Gastric Cancer Drugs Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Gastric Cancer Drugs Revenue Market Share by Countries (2015-2020)
Table 96. Global Gastric Cancer Drugs Sales by Type (2015-2020) (K Pcs)
Table 97. Global Gastric Cancer Drugs Sales Share by Type (2015-2020)
Table 98. Global Gastric Cancer Drugs Revenue by Type (2015-2020) (USD Million)
Table 99. Global Gastric Cancer Drugs Revenue Share by Type (2015-2020)
Table 100. Global Gastric Cancer Drugs Sales by Application (2015-2020) (K Pcs)
Table 101. Global Gastric Cancer Drugs Sales Share by Application (2015-2020)
Table 102. Global Gastric Cancer Drugs Sales Forecast by Regions (2021-2025) (K Pcs)
Table 103. Global Gastric Cancer Drugs Market Share Forecast by Regions (2021-2025)
Table 104. Global Gastric Cancer Drugs Sales Forecast by Type (2021-2025) (K Pcs)
Table 105. Global Gastric Cancer Drugs Market Share Forecast by Type (2021-2025)
Table 106. Global Gastric Cancer Drugs Sales Forecast by Application (2021-2025)
Table 107. Global Gastric Cancer Drugs Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Gastric Cancer Drugs Picture
Figure 2. Global Sales Market Share of Gastric Cancer Drugs by Type in 2019
Figure 3. Doxorubicin Hydrochloride Picture
Figure 4. Sunitinib Picture
Figure 5. Docetaxel Picture
Figure 6. Mitomycin Picture
Figure 7. Fluorouracil Picture
Figure 8. Imatinib Picture
Figure 9. Trastuzumab Picture
Figure 10. Gastric Cancer Drugs Sales Market Share by Application in 2018
Figure 11. Hospitals Picture
Figure 12. Clinics Picture
Figure 13. Other Picture
Figure 14. Global Gastric Cancer Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Gastric Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Gastric Cancer Drugs Sales Market Share by Manufacturer in 2019
Figure 35. Global Gastric Cancer Drugs Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Gastric Cancer Drugs Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Gastric Cancer Drugs Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Gastric Cancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Gastric Cancer Drugs Revenue Market Share by Regions (2015-2020)
Figure 42. Global Gastric Cancer Drugs Revenue Market Share by Regions in 2018
Figure 43. North America Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
Figure 44. Europe Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
Figure 46. South America Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Gastric Cancer Drugs Sales and Growth Rate (2015-2020)
Figure 48. North America Gastric Cancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Gastric Cancer Drugs Sales Market Share by Countries (2015-2020)
Figure 50. North America Gastric Cancer Drugs Sales Market Share by Countries in 2018
Figure 51. North America Gastric Cancer Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Gastric Cancer Drugs Revenue Market Share by Countries in 2018
Figure 53. United States Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Gastric Cancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Gastric Cancer Drugs Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Gastric Cancer Drugs Revenue Market Share by Countries in 2019
Figure 59. Germany Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Gastric Cancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Gastric Cancer Drugs Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Gastric Cancer Drugs Revenue Market Share by Regions 2019
Figure 67. China Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Gastric Cancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Gastric Cancer Drugs Sales Market Share by Countries in 2019
Figure 74. South America Gastric Cancer Drugs Revenue Market Share by Countries in 2019
Figure 75. Brazil Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Gastric Cancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Gastric Cancer Drugs Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Gastric Cancer Drugs Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Gastric Cancer Drugs Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Gastric Cancer Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Gastric Cancer Drugs Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Gastric Cancer Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Gastric Cancer Drugs Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Gastric Cancer Drugs Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Gastric Cancer Drugs Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Gastric Cancer Drugs Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Gastric Cancer Drugs Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
胃がん治療薬の世界市場（～2026年） Gastric cancer drugs are used to treat malignancies, or cancerous growths. The APAC region to account for the highest market share during the forecast period. Much of this region’s growth can be attributed to the increasing demand for better healthcare infrastructure, which results in its massive ma…- 膵臓がん治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Pancreatic Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pancreatic …
- 頭頸部がん治療薬/治療の世界市場（～2026年） Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…
- 腎臓/腎がん治療薬の世界市場（～2026年） Kidney/Renal Cancer Drugs are used to cure kidney cancers. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors bo…
- 尿管がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ureter Cancer Drugs Market The global Ureter Cancer Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ureter Cancer Drugs Scope and Market Size Ureter Cancer Drugs market is seg…